| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $196.6M | — | +11.1% |
| Cost of Revenue | $71.8M | — | +12.0% |
| Gross Profit | $124.9M | — | +10.5% |
| R&D Expense | $24.6M | — | +17.5% |
| SG&A Expense | $54.3M | — | +20.7% |
| Operating Income | -$10.6M | — | -336.4% |
| Pre-tax Income | -$9.6M | — | -260.1% |
| Income Tax | -$7.1M | — | -39.8% |
| Net Income | -$2.5M | — | -122.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $252.5M | -19.6% | -6.6% |
| Accounts Receivable | $159.0M | -13.3% | +4.4% |
| Current Assets | $488.5M | -12.9% | -3.3% |
| Total Assets | $1.21B | -4.4% | +5.2% |
| Current Liabilities | $566.6M | -1.4% | +10.4% |
| Long-term Debt | $338.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $38.0M | — | +156.5% |
| Investing Cash Flow | -$52.3M | — | -193.0% |
| Financing Cash Flow | -$53.3M | — | -158.2% |
| +0.7% |
| Total Liabilities | $967.9M | -4.4% | +1.5% |
| Stockholders' Equity | $246.5M | -4.8% | +23.0% |